373 results on '"Brodin, E."'
Search Results
2. CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL
3. OP0058 CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONAL THERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STAR TRIAL
4. An Animal Model for the Study of Brain Transmittor Release in Response to Spinal Cord Stimulation in the Awake, Freely Moving Rat: Preliminary Results from the Periaqueductal Grey Matter
5. Comparison of ultrasound assisted catheter-directed thrombolysis (CDT) and CDT alone for treatment of proximal deep vein thrombosis: OR258
6. Regular physical activity and future risk of myocardial infarction and venous thrombosis - the tromsø study: OR075
7. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment
8. A Substance P Antagonist Inhibits Vagally Induced Increase in Vascular Permeability and Bronchial Smooth Muscle Contraction in the Guinea Pig
9. Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study
10. Impact of different measures of renal impairment on future risk of venous thromboembolism. The Tromsø study: PB 2.70–3
11. Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -the Tromsø study: PB 1.70–1
12. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsφ
13. Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsφ study
14. The Swedish version of the Haemophilia Activity List
15. OP0018 A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL
16. Session S2.3: The Swedish haemophiliacʼs self reported activity and function in daily life: reported with HAL, AIMS 2, and IPA: 27FP09
17. Analysis of a diary written by a woman with acquired haemophilia A postpartum, in a narrative approach - a case report: 30P39
18. Elimination of human recombinant mammalian tissue factor pathway inhibitor in a rat model: OC-MO-058
19. Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis
20. PS1482 EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS) ON ENDOTHELIAL CELLS AND NEUTROPHIL EXTRACELLULAR TRAP (NET) FORMATION IN IMMUNE THROMBOCYTOPENIA (ITP)
21. Spinal expression of mRNA for immediate early genes in a model of chronic pain
22. Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain
23. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study
24. NO RELEASE OF HISTAMINE OR SUBSTANCE IN CAPSAICIN-INDUCED NEUROGENIC INFLAMMATION IN INTACT HUMAN SKIN IN VIVO : 308
25. Chapter 28 Restoration of function to the denervated spinal cord after implantation of embryonic 5HT- and substance P-containing raphe neurones
26. Self-reported activity of Swedish persons with haemophilia: Change over 2.5 years
27. The european hematology association roadmap for european hematology research: A consensus document
28. Striato-Nigral Tachykinin Neurons and Influence from Striatal Dopamine and GABA
29. Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen: Biochemical and immunohistochemical evidence
30. Peptide-containing neurons intrinsic to the gut wall: An experimental study in the pig
31. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells
32. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation
33. Calcitonin gene-related peptide-like immunoreactivity in nerve fibers in the human skin: Relation to fibers containing substance P-, somatostatin- and vasocactive intestinalpolypeptide-like immunoreactivity
34. Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone
35. Abstracts
36. Immunoreactive substance P in the chicken gut: Distribution, development and possible functional significance
37. Modelling, estimation and visualization of multivariate dependence for high-frequency data
38. Extreme value theory in finance
39. IMMUNOHISTOCHEMICAL LOCALIZATION OF SUBSTANCE P IN MOUSE GUT
40. Localization of substance P-like immunoreactivity in mouse gut
41. Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P
42. Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study
43. F104 RESOLVINS AND LIPOXINS ATTENUATE CARRAGEENAN-INDUCED INFLAMMATORY PAIN
44. Spinal Astrocytes in Pain Processing: Non-Neuronal Cells as Therapeutic Targets
45. Pharmacology — a historical overview
46. Commentary. The employment status of ministers of religion
47. Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey
48. Spatiotemporal selective effects on brain-derived neurotrophic factor andtrkB messenger RNA in rat hippocampus by electroconvulsive shock
49. Measurement of central neuropeptide release by microdialysis
50. Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.